Clinical Trial Update: A Study of Docetaxel for Injection (Albumin-bound) in Patients With Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for albumin-bound docetaxel in pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Docetaxel for Injection (Albumin Bound) (docetaxel (albumin-bound formulation))

Snippet

Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Conditions: Pancreatic Cancer | Phase 2 | Status: UNKNOWN